enGene Funding: $135M Raised, Growth (2023)

enGene funding overview

enGene is based in Montreal, Canada. enGene has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in May 2023. The round record for enGene runs through 2023; nothing later has been disclosed. Investors on record include Forbion Growth, BVF Partners, Omega Funds, Cowen Healthcare Investments, Investissement Québec, Vivo Capital and 5 others. 11 distinct backers are named across the disclosed rounds.

enGene at a glance

Total raised: $135M
Latest round: Growth
Latest round date: May 2023
Headquarters: Montreal, Canada
Notable investors: Forbion Growth, BVF Partners, Omega Funds, Cowen Healthcare Investments, Investissement Québec, Vivo Capital, Northleaf Capital Partners, CTI Life Sciences Fund III

Frequently asked about enGene funding

How much has enGene raised?: enGene has raised $135M in total disclosed funding across the rounds on record.
Who has invested in enGene?: Forbion Growth, BVF Partners, Omega Funds, Cowen Healthcare Investments, Investissement Québec, Vivo Capital are named among the investors backing enGene.
What was the latest enGene funding round?: The most recent disclosed round is a Growth, announced in May 2023.
Where is enGene based?: enGene is based in Montreal, Canada.
When did enGene last raise?: The last disclosed enGene round closed in May 2023 at Growth.

We update the enGene record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Montreal and their backers are listed below.

enGene Funding: $135M Raised, Growth (2023)

enGene funding overview

enGene at a glance

Frequently asked about enGene funding

Companies related to enGene (19)

Browse related funding lists (8)